Gara Jalqabaatti › Kansara Metastatikii › Wisconsin › Madison
Qorannoo klinikaalii Kansara Metastatikii Madison, WI keessatti
Qorannoo 21 Kansara Metastatikii f Madison fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Namoota walitti qabaa jiraSadarkaa 3
- University of Wisconsin Carbone Cancer Center, Madison
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Namoota walitti qabaa jiraSadarkaa 2
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
Namoota walitti qabaa jiraSadarkaa 1
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Wisconsin Carbone Cancer Center, Madison
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Namoota walitti qabaa jiraSadarkaa 1
- University of Wisconsin - Carbone Cancer Center, Madison
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Wisconsin Institute for Medical Research, Madison
A Study of ASP3082 in Adults With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- University of Wisconsin Hospital, Madison
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 3
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- SSM Health Dean Medical Group - South Madison Campus Health Research/Circuit Clinical, Madison
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Biomarkers to Detect Endocrine Therapy Resistance
Namoota walitti qabaa jiraSadarkaa 2
- UW Carbone Cancer Center, Madison
Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer
Namoota walitti qabaa jiraSadarkaa 1
- UW Carbone Cancer Center, Madison
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Wisconsin, Carbone Cancer Center, Madison
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
Namoota walitti qabaa jiraSadarkaa 1
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Namoota walitti qabaa jiraSadarkaa 1
- University of Wisconsin, Madison
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Namoota walitti qabaa jiraSadarkaa 2/3
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Namoota walitti qabaa jiraSadarkaa 2/3
- University Of Wisconsin Carbone Cancer Center - University Hospital, Madison
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- UW Carbone Cancer Center, Madison
IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)
Namoota walitti qabaa jiraSadarkaa 1
- University of Wisconsin Carbone Cancer Center, Madison
Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers
Namoota walitti qabaa jiraSadarkaa 1
- SSM Health Cancer Care, Madison
In Vivo Liquid Biopsy of Melanoma (Cytophone)
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- SSM Health Dean Medical Group Specialty Services, Madison
Qorannoo Kansara Metastatikii magaalota biroo keessatti
- Houston, TXQorannoo 104
- New York City, NYQorannoo 93
- Nashville, TNQorannoo 70
- Boston, MAQorannoo 63
- Los Angeles, CAQorannoo 57
- St. Louis, MOQorannoo 54
- Arlington, VAQorannoo 53
- Philadelphia, PAQorannoo 46
- Chicago, ILQorannoo 45
- San Antonio, TXQorannoo 44
- Washington, DCQorannoo 43
- Dallas, TXQorannoo 42
Qorannoo biroo Madison keessatti
- Kansarii ProstateQorannoo 29
- Kansarii ColorectalQorannoo 23
- Saree OljooQorannoo 22
- Leukemia Myeloidii HamaaQorannoo 16
- Kansara Qara'a Non-Small CellQorannoo 16
- MelanomaQorannoo 15
- Saree (Gosoota Hunda)Qorannoo 14
- Kansarii OvariiQorannoo 13
- Kanisa HarkaaQorannoo 11
- Kansarii PancreasQorannoo 10
- Dhibee QaraQorannoo 10
- Myeloma Baay’eeQorannoo 9
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.